Osteoprotegerin ligand: A common link between osteoclastogenesis, lymph node formation and lymphocyte development

Immunology and Cell Biology

Volumn 77, Issue 2, 1999, Pages 188-193

  Kong, Young Yun ^a   Boyle, William J ^b   Penninger, Josef M ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b AMGEN INC   (United States)

^c AMGEN INSTITUTE   (Canada)

Author keywords

Lymph node genesis; Lymphocyte development; Osteoclastogenesis; Osteoprotegerin ligand

Indexed keywords

ANIMAL CELL; BONE REMODELING; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; CONFERENCE PAPER; DENDRITIC CELL; IMMUNE SYSTEM; LIGAND BINDING; LYMPH NODE CELL; MORPHOGENESIS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; SIGNAL TRANSDUCTION; STEM CELL; STROMA CELL;

ANIMALS; CARRIER PROTEINS; EMBRYONIC AND FETAL DEVELOPMENT; GLYCOPROTEINS; HUMANS; IMMUNE SYSTEM; LYMPH NODES; MEMBRANE GLYCOPROTEINS; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR;

ANIMALIA;

EID: 0032917871     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1999.00815.x     Document Type: Conference Paper

References (45)

1. Felix R, Hofstetter W, Cecchini MG. Recent developments in the understanding of the pathophysiology of osteopetrosis. Eur. J. Endocrinol. 1996; 134: 143-56.
2. Roodman GD. Advances in bone biology: The osteoclast. Endocr. Rev. 1996; 17: 308-32.
3. Suda T, Nakamura I, Jimi E, Takahashi N. Regulation of osteoclast function. J. Bone Miner. Res. 1997; 12: 869-79.
4. Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N. Modulation of osteoclast differentiation by local factors. Bone 1995; 17: S87-91.
5. Heymann D, Guicheux J, Gouin F, Passuti N, Daculsi G. Cytokines, growth factors and osteoclasts. Cytokine 1998; 10: 155-68.
6. Lagasse E, Weissman IL. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 1997; 89: 1021-31.
7. Lacey DL, Timms E, Tan HL et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165-76.
8. Simonet WS, Lacey DL, Dunstan CR et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309-19.
9. Yasuda H, Shima N, Nakagawa N et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and is identical to TRANCE/RANKL. Proc. Natl Acad. Sci. USA 1998; 95: 3597-602.
10. Yasuda H, Shima N, Nakagawa N et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998; 139: 1329-37.
11. Bucay N, Sarosi L, Dunstan CR et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998; 12: 1260-8.
12. Mizuno A, Amizuka N, Irie K et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem. Biophys. Res. Commun. 1998; 247: 610-15.
13. 2 in human bone marrow stroma cells. Biochem. Biophys. Res. Commun. 1998; 247: 338-41.
14. Filvaroff E, Derynck R. Bone remodelling: A signalling system for osteoclast regulation. Curr. Biol. 1998; 8: R679-82.
15. 2, or parathyroid hormone in the microenvironment of bone. Biochem. Biophys. Res. Commun. 1998; 246: 337-41.
16. Rodan GA, Martin TJ. Role of osteoblasts in hormonal control of bone resorption - a hypothesis. Calcif. Tissue Int. 1981; 33: 349-51.
17. Kong Y-Y, Yoshida H, Sarosi I et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis. Nature 1999; 397: 315-23.
18. Grigoriadis AE, Wang ZQ, Cecchini MG et al. c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994; 266: 443-8.
19. Franzoso G, Carlson L, Xing L et al. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 1997; 11: 3482-96.
20. Iotsova V, Caamano J, Loy J et al. Osteopetrosis in mice lacking NF-kappB1 and NF-kappB2. Nat. Med. 1997; 3: 1285-9.
21. Wong BR, Rho J, Arron J et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 1997; 272: 25 190-4.
22. Anderson DM, Maraskovsky E, Billingsley, WL et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997; 390: 175-9.
23. De Togni P, Goellner J, Ruddle NH et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994; 264: 703-7.
24. Rennert PD, James D, Mackey F, Browning JL, Hochman PS. Lymph node genesis is induced by signaling through the lymphotoxin β receptor. Immunity 1998; 9: 71-9.
25. Koni PA, Sacca R, Lawton P et al. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 1997; 6: 491-500.
26. Alimzhanov MB, Kuprash DV, Kosco-Vilbois MH et al. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc. Natl Acad. Sci. USA 1997; 94: 9302-7.
27. Matsumoto M, Mariathasan S, Nahm MH et al. Role of lymphotoxin and the type 1 TNF receptor in the formation of germinal centers. Science 1996; 271: 1289-91.
28. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNT alpha-deficient mice: A critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 1996; 184: 1397-411.
29. Futterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K. The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998; 9: 59-70.
30. Chaplin DD, Fu Y. Cytokine regulation of secondary lymphoid organ development. Curr. Opin. Immunol. 1998; 10: 289-97.
31. + cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 1997; 7: 493-504.
32. Anderson G, Moore NC, Owen JJ, Jenkinson EJ. Cellular interactions in thymocyte development. Annu. Rev. Immunol. 1996; 14: 73-99.
33. von Boehmer H, Fehling HJ. Structure and function of the pre-T cell receptor. Annu. Rev. Immunol. 1997; 15: 433-52.
34. Fehling HJ, Krotkova A, Saint-Ruf C, von Boehmer H. Crucial role of the pre-T-cell receptor alpha gene in development of alpha beta but not gamma delta T cells. Nature 1995; 375: 795-8.
35. Reed DS, Olson S, Lefrancois L. Glycosyltransferase regulation mediated by pre-TCR signaling in early thymocyte development. Int. Immunol. 1998; 10: 445-51.
36. Cheng AM, Negishi I, Anderson SJ et al. The Syk and ZAP-70 SH2-containing tyrosine kinases are implicated in pre-T cell receptor signaling. Proc. Natl Acad. Sci. USA 1997; 94: 9797-801.
37. Clements JL, Yang B, Ross-Barta SE et al. Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development. Science 1998; 281: 416-19.
38. Irving BA, Alt FW, Killeen N. Thymocyte development in the absence of pre-T cell receptor extracellular immunoglobulin domains. Science 1998; 280: 905-8.
39. Turner M, Mee PJ, Walters AE et al. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity 1997; 7: 451-60.
40. Moore TA, von Freeden-Jeffry U, Murray R, Zlotnik A. Inhibition of gamma delta T cell development and early thymocyte maturation in IL-7 -/- mice. J. Immunol. 1996; 157: 2366-73.
41. Wong BR, Josien R, Lee SY et al. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 1997; 186: 2075-80.
42. Akagawa KS, Takasuka N, Nozaki Y et al. Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood 1996; 88: 4029-39.
43. Saoulli K, Lee SY, Cannons JL et al. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J. Exp. Med. 1998; 187: 1849-62.
44. Mombaerts P, Takasuka N, Nozaki Y et al. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993; 75: 274-82.
45. Horton JE, Raisz LG, Simmons HA, Oppenheim JJ, Mergenhagen SE. Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science 1972; 177: 793-5.